| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.7326/0003-4819-128-2-199801150-00002 |
| P698 | PubMed publication ID | 9441587 |
| P50 | author | Gordon Guyatt | Q5585214 |
| P2093 | author name string | H C Bucher | |
| L E Griffith | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| P304 | page(s) | 89-95 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | Annals of Internal Medicine | Q564416 |
| P1476 | title | Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials | |
| P478 | volume | 128 |
| Q33862438 | Atheromas of the thoracic aorta: clinical and therapeutic update |
| Q78652087 | Atherosclerosis of the thoracic aorta: from risk stratification to treatment |
| Q28196396 | Benefits of optimising drug treatment in home-dwelling elderly patients with coronary artery disease |
| Q37639156 | CHADS2 and CHA2DS2-VASc Scores Predict the Risk of Ischemic Stroke Outcome in Patients with Interatrial Block without Atrial Fibrillation |
| Q44456918 | Chitosan decreases total cholesterol in women: a randomized, double-blind, placebo-controlled trial |
| Q79756378 | Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy |
| Q34107346 | Cholesterol, stroke risk, and stroke prevention |
| Q41825556 | Clinical profile of stroke:: The experience at King Abdulaziz University Hospital |
| Q93918245 | Clinical trials in stroke |
| Q35639538 | Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry |
| Q42787552 | Controlling glucose and blood pressure in type 2 diabetes |
| Q33963084 | Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque |
| Q33815841 | Efficacy of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for prevention of stroke |
| Q34530720 | Estrogen, statins, and polyunsaturated fatty acids: similarities in their actions and benefits-is there a common link? |
| Q74261521 | Evidence-based treatment of patients with ischemic cerebrovascular disease |
| Q57338286 | GRADE-Leitlinien: 2. Formulierung der Fragestellung und Entscheidung über wichtige Endpunkte |
| Q34236671 | HMG-CoA reductase inhibitors |
| Q24240060 | Interventions in the management of serum lipids for preventing stroke recurrence |
| Q34757974 | Interventions in the management of serum lipids for preventing stroke recurrence. |
| Q34029742 | Is Canada falling behind international standards for stroke care? |
| Q50668031 | Ischemic Stroke Prevention. |
| Q33335379 | Issues and challenges in the assessment, diagnosis and treatment of cardiovascular risk factors: assessing the needs of cardiologists |
| Q35808362 | JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice |
| Q77569194 | Low-density lipoproteins and risk for coronary artery disease |
| Q34219027 | Management of UTI in general practice: a cost effective analysis. A commentary to facilitate an understanding of economic evaluation |
| Q35148392 | Management of dyslipidemia: an update |
| Q35008527 | Medical therapy for secondary prevention of stroke |
| Q34312630 | Methodological issues and therapeutic perspectives in vascular dementia: a review |
| Q80833407 | New strategies in the medical treatment of carotid artery disease |
| Q36409262 | New strategies in the medical treatment of carotid artery disease |
| Q44524789 | Non-lipid effects of statins: myth or fact? |
| Q28219321 | Ongoing clinical trials of the pleiotropic effects of statins |
| Q51464560 | Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease. |
| Q44427254 | Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia |
| Q35818904 | Prevention and treatment of stroke in patients with hypertension |
| Q74654793 | Prevention of Ischemic Stroke |
| Q34993307 | Prevention of cardiovascular diseases. Coronary artery disease, congestive heart failure, and stroke |
| Q28192311 | Prevention of ischemic stroke |
| Q44053357 | Projected life-expectancy gains with statin therapy for individuals with elevated C-reactive protein levels |
| Q36753684 | Psychiatric adverse reactions with statins, fibrates and ezetimibe: implications for the use of lipid-lowering agents |
| Q24679573 | Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis |
| Q24792305 | Rising statin use and effect on ischemic stroke outcome |
| Q83158874 | Secondary prevention in patients with cerebrovascular ischaemic disease |
| Q35457797 | Serum lipids in young patients with ischaemic stroke: a case-control study |
| Q44761374 | Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia |
| Q36307314 | Statins and cognition: what can we learn from existing randomized trials? |
| Q81884102 | Statins and stroke prevention |
| Q34219006 | Statins and the prevention of coronary heart disease: striking a balance that is desirable, affordable, and achievable. |
| Q74452852 | Statins for prevention of stroke |
| Q34804715 | Task force #1--magnitude of the prevention problem: opportunities and challenges. 33rd Bethesda Conference |
| Q34008166 | The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: data from the Heart and Soul Study |
| Q60712642 | The Recognition, Assessment and Management of Dementing Disorders: Conclusions from the Canadian Consensus Conference on Dementia |
| Q35825959 | The effect of hypertension and hypercholesterolemia screening with subsequent intervention letter on the use of blood pressure and lipid lowering drugs |
| Q34219017 | The primary prevention of coronary heart disease with statins: practice headache or public health? |
| Q33996158 | The relationship between cholesterol and stroke: implications for antihyperlipidaemic therapy in older patients |
| Q33665220 | Transesophageal echocardiography for the evaluation and management of patients with cerebral ischemia. |
| Q34310282 | Treating dyslipidaemia in non-insulin-dependent diabetes mellitus -- a special reference to statins |
| Q33763932 | Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. |
| Q78006813 | [Angiology update] |
| Q52916869 | [Meta-analysis, megatrials, and clinical practice in cardiology] |
| Q74639187 | [Prevention of coronary heart disease--"evidence-based medicine" of antilipemic therapy] |
Search more.